Press Releases

Mitchell Kane Named Practice Leader for Constella Health Strategies

"Mitchell possesses an extraordinary breadth of knowledge that spans the worlds of finance, accounting, and commercial sales and marketing," said Donato Tramuto, president and CEO of Constella Health Strategies. "This mix of skills and experiences uniquely positions him to address the market challenges that our clients face daily. His vast experience in strategic planning, sales, marketing and commercialization will augment our service capabilities as we create a fully-integrated program offering to our clients."

Kane previously served as vice president and chief financial officer for TrialCard Inc., an entrepreneurial start-up that provides advertising, marketing and strategic information and services to the pharmaceutical industry. Prior to that position, he spent 15 years with GlaxoSmithKline in a variety of senior management positions, most recently as vice president of pricing strategy and commercial support services. He also has held senior management positions with Vanity Fair Corporation/Blue Bell, Inc. and The Austin Company.

"When I work with clients, I like to evaluate their comprehensive business strategy in addition to all the critical elements of their commercialization efforts," said Kane. "It is important to understand how an organization invests and leverages all of its available resources in an integrated manner to ensure that those activities are consistent and complementary with its strategic plan. If an organization does this better than the competition, it is more likely to optimize its return on investment for each individual product, product portfolio and all ancillary service offerings."

Kane, a certified public accountant, received his M.B.A from The Kenan-Flagler Business School at the University of North Carolina at Chapel Hill, and a B.A. from Valdosta State University.

About Constella Health Strategies
Constella Health Strategies is a premier evidence-based, health-care consulting business that helps pharmaceutical, biotechnology and medical device companies around the world accelerate medical therapies to market. Employing one of the largest and most experienced clinical, analytic, technical, and business development teams in the nation, Constella Health Strategies evaluates the best way to use drugs and to provide health care through expert analysis of proprietary databases, consensus panels and scientific literature. Its multidisciplinary staff also designs, develops and implements disease management and other clinically directed programs to reduce unnecessary costs, improve quality, and enhance patient and provider satisfaction.

About Constella Group, Inc.
Constella Group, Inc., formerly named Analytical Sciences, Inc. (ASI), is a leading provider of professional health services worldwide, now celebrating 20 years of enhancing human health through innovative science, technology and knowledge solutions. Constella's three business units—Health Sciences, Biomedical Informatics and Health Strategies—conduct health research and provide a variety of technical, professional and strategic consulting services to help industry and government clients identify and solve problems affecting human health. The company's 640 employees serve clients from company headquarters in Durham, N.C., and from offices in Atlanta; Austin, Texas; Morgantown, W.Va.; Bethesda, Frederick and Silver Spring, Md.; and in Santa Monica, Calif.; Herndon, Va.; and Boston.